Changes in Adenosine Deaminase Activity in Patients with Type 2 Diabetes Mellitus and Effect of DPP-4 Inhibitor Treatment on ADA Activity
BackgroundDipeptidyl peptidase 4 (DPP-4, also known as CD26) binds with adenosine deaminase (ADA) to activate T lymphocytes. Here, we investigated whether ADA activity is specifically affected by treatment with DPP-4 inhibitor (DPP4I) compared with other anti-diabetic agents.MethodsFasting ADA activ...
Main Authors: | Jae-Geun Lee, Dong Gu Kang, Jung Re Yu, Youngree Kim, Jinsoek Kim, Gwanpyo Koh, Daeho Lee |
---|---|
Format: | Article |
Language: | English |
Published: |
Korean Diabetes Association
2011-04-01
|
Series: | Diabetes & Metabolism Journal |
Subjects: | |
Online Access: | http://e-dmj.org/Synapse/Data/PDFData/2004DMJ/dmj-35-149.pdf |
Similar Items
-
Molecular Evidence of Adenosine Deaminase Linking Adenosine A2A Receptor and CD26 Proteins
by: Estefanía Moreno, et al.
Published: (2018-02-01) -
Adenosine Deaminase and Guanosine Deaminase Activities in Sera of Patients with Viral Hepatitis
by: Kalkan Ahmet, et al.
Published: (1999-01-01) -
Evaluation of adenosine deaminase (ADA) and ADA1 and ADA2 isoenzyme activities in patients with pulmonary tuberculosis and tuberculous pleurisy
by: O O Yanovich, et al.
Published: (2015-01-01) -
Adenosine deaminase, (ADA) level in leprosy
by: I S I Ogbu, et al.
Published: (2012-01-01) -
The use of adenosine deaminase activity (ADA) for the diagnosis of tuberculous peritonitis
by: R Hortiwakul, et al.
Published: (2005-04-01)